Owner GeneNews Limited

Convention CA 16 April 2008 1391683

Service Blake Dawson Level **** Street MELBOURNE VIC 3000

Filing Date 16 October 2008

Class 5 Diagnostic preparations, including preparations of extracts, nucleic acids including RNA and CDNA clones for clinical or medical laboratory use; diagnostic preparations, including assays, and polymerase chain reaction (PCR) and real time pcr primers, proteins and antibodies, and molecular arrays of biological material for clinical or medical laboratory use; prescription pharmaceutical preparations for use in diagnosing and treating human diseases and conditions, including respiratory diseases and conditions, endocrine diseases and conditions, including hormonal disorders, diabetes, pancreas disorders, pituitary disorders, thyroid disorders, and adrenal disorders, neurologic diseases and conditions, including brain injury, spinal cord injury, seizure disorders, alzheimer's, manic depression, schizophrenia, and parkinson's disease, cardiovascular diseases and conditions, alimentary diseases and conditions, including dyspepsia, diarrhea, and dysentery, gastrointestinal diseases and conditions, including gastroesophogeal reflux disease, gastritis, peptic ulcers, constipation, diarrhea, gastroenteritis, irritable bowel syndrome, colitis, and chron's disease, renal diseases and conditions, including renal failure, nephrolithiasis, renal calcification, renal carbuncle, renal colic, and glomerular nephritis, metabolic diseases and conditions, including diabetes, sodium metabolism disorders, calcium metabolism disorders, potassium metabolism disorders, magnesium metabolism disorders, phosphate metabolism disorders, acid-base metabolism disorders, and lysosomal storage diseases, central nervous system diseases and conditions, including central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, and spinal cord diseases, weight disorders, including obesity, anorexia nervosa, and bulimia nervosa, oncologic diseases and conditions, auto-immune or imumune-related diseases and conditions, including autoimmune diseases and immunologic deficiency syndromes, pulmonary diseases and conditions, including chronic obstructive pulmonary disease, emphysema, asthma, and bronchitis, musculo-skeletal diseases and conditions, including osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, osteoporosis, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, and cartilage injuries, and lymphatic diseases and conditions, including lymphedema, lymphoma, and splenic diseases

Class 9 Computer storage media including, computer tapes, computer discs and CD-ROMs, providing genomic, proteomic and gene expression profile information for use in selecting therapeutics, evaluating efficacy and toxicity of treatments, evaluating treatment progression, prognosing disease or disease progression, and identifying disease heredity risk factors

Class 10 Diagnostic assays and test kits for use in clinical, laboratory, medical, and chemical research and development and used to diagnose, prognose, predict or treat diseases; prognostic test kits for identifying disease risk factors and responses to therapeutic treatment

Class 42 Research and development, validation testing, data analysis and product development in the fields of biology, systems biology, biochemistry, molecular biology, genomics, proteomics, diagnostics, toxicogenomics, pharmacogenomics and personalized medicine; computer services, including computer tracking of and providing access to databases of life sciences information via global, national and local computer networks in the field of pharmacogenomics, diagnostics, personalized medicine and toxicogenomics

Class 44 Diagnostic services, including diagnosing, preventing and predicting disease, identifying risk factors of disease, prognostic testing, gene and protein testing, identifying physiological characteristics, and evaluating efficacy of treatment; medical and diagnostic services, including diagnosing, preventing and predicting disease, identifying disease risk factors, diagnostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative care programs, establishing disease treatment based on gene and protein expression and/or activity, evaluating clinical trial progress, and drug monitoring and monitoring of patient health progression; providing genomic, proteomic and gene expression profiles useful in selecting therapeutics, evaluating the efficacy and toxicity of treatments and evaluating treatment progression, prognosing disease or disease progression and identifying disease heredity risk factors